General Information of the Compound
| Compound ID |
CP0576091
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-methyl-1-[2-[4-[[4-(2,2,2-trifluoroethoxy)phenyl]methyl]piperazine-1-carbonyl]-6-[5-[3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]oxyindol-1-yl]propan-1-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C39H33F6N7O5
|
||||||||||||||||||
| Molecular Weight |
793.725
|
||||||||||||||||||
| Canonical SMILES |
CC(C)C(=O)n1c(cc2ccc(Oc3cnc(cn3)-c3nc(no3)-c3ccc(cc3)C(F)(F)F)cc12)C(=O)N1CCN(Cc2ccc(OCC(F)(F)F)cc2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C39H33F6N7O5/c1-23(2)36(53)52-31-18-29(56-33-20-46-30(19-47-33)35-48-34(49-57-35)25-5-8-27(9-6-25)39(43,44)45)12-7-26(31)17-32(52)37(54)51-15-13-50(14-16-51)21-24-3-10-28(11-4-24)55-22-38(40,41)42/h3-12,17-20,23H,13-16,21-22H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
IFPFNBUYEOKMBV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound